Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT00533884
Official study title

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

Study summary

RATIONALE: Gathering information about how often problems with neurocognitive functioning occur in patients with newly diagnosed upper aerodigestive tract cancers may help doctors learn more about the disease. PURPOSE: This clinical trial is studying neurocognitive functioning in patients with newly diagnosed upper aerodigestive tract cancers receiving treatment at Henry-Joyce Cancer Clinic.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedAssessment of therapy complications and Neurocognitive assessment

Plus 1 other study approaches.

Who it may be forNeurocognitive Impairment · Delirium

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 7, 2017 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?4 U.S. locations

Locations may change over time.

Who runs it?Vanderbilt University Medical Center

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Vanderbilt University Medical Center
Interventions being studied
Other: Assessment of therapy complications; Other: Neurocognitive assessment; Other: Quality-of-life assessment
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • DISEASE CHARACTERISTICS:
  • Newly diagnosed solid tumors of the upper aerodigestive system, including cancers of the head and neck, esophagus, or lung
  • Receiving treatment at the Henry-Joyce Cancer Clinic at the Vanderbilt-Ingram Cancer Center
  • No known brain metastasis PATIENT CHARACTERISTICS:
  • Able to hear, speak, and understand English
  • No prior diagnosis of other cancer except basal cell carcinoma PRIOR CONCURRENT THERAPY:
  • No treatment plans including prophylactic cranial irradiation

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Vanderbilt-Ingram Cancer Center - Cool SpringsNashville, Tennessee
  • Vanderbilt-Ingram Cancer Center at FranklinNashville, Tennessee
  • MBCCOP - Meharry Medical College - NashvilleNashville, Tennessee
  • Vanderbilt-Ingram Cancer CenterNashville, Tennessee

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 7, 2017. Always confirm current availability with the study team.

View original record ↗